Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story
Amgen stock represents one of the most established names in the global biotechnology sector, with Amgen Inc. (ISIN US0311621009) widely recognized for its focus on innovative human therapeutics and its longstanding listing on the Nasdaq in the United States. As a large-cap biotech company, Amgen generates substantial recurring revenue from a diversified portfolio of biologic…